Home
Conditions
Perivascular Epithelioid Cell Neoplasms

Clinical trial condition

Perivascular Epithelioid Cell Neoplasms

Explore clinical trials studying Perivascular Epithelioid Cell Neoplasms. Study availability and eligibility vary by location and protocol.

48 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Perivascular Epithelioid Cell Neoplasms trial results

Completed

The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients

NCT02859194

Conditions: ARDS (Acute Respiratory Distress Syndrome), Acute Lung Injury, Bronchial Diseases, +27 more
Locations: Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine Seoul, South Korea

View Trial Details

Completed

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

NCT00790400

Conditions: Angiomyolipoma, Astrocytoma, Congenital Abnormalities, +43 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Barrow Tuberous Sclerosis Center Phoenix, Arizona, United States

Massachusetts General Hospital Massachussetts General Hospita Boston, Massachusetts, United States

Minnesota Epilepsy Group Saint Paul, Minnesota, United States

View all 25 locations

View Trial Details

Completed

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

NCT02116712

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Cincinnati Cincinnati, Ohio, United States

Baylor College of Medicine Houston, Texas, United States

University of Texas Health Science Center-Houston Houston, Texas, United States

View Trial Details

Completed

Lymphangioleiomyomatosis (LAM) Registry

NCT00005486

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: Not specified

View Trial Details

Completed

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

NCT02009241

Conditions: Behavior, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Pulmonary Division, Heart Institute (InCor), University of Sao Paulo Medical School São Paulo, Brazil

View Trial Details

Completed

Doxycycline In Lymphangioleiomyomatosis (LAM)

NCT00989742

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
Locations: Nottingham University Hospitals Nottingham, United Kingdom

View Trial Details

Completed

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

NCT00457964

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +27 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis

NCT01217125

Conditions: Angiomyolipoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations: Not specified

View Trial Details

Completed

Pulmonary Hypertension in Lymphangioleiomyomatosis

NCT00960895

Conditions: Cardiovascular Diseases, Hemic and Lymphatic Diseases, Hypertension, +16 more
Locations: Louis Pradel Hospital Lyon, University of Lyon, France

View Trial Details

Completed

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

NCT00005906

Conditions: Ascites, Chylothorax, Chylous Ascites, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Perivascular Epithelioid Cell Neoplasms

Perivascular Epithelioid Cell Neoplasms trial results

Related conditions